resTORbio Company

resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.The Company develops medicines and therapies to treat aging-related diseases and conditions such as cancer, heart disease, neurodegenerative diseases, and diabetes mellitus. resTORbio serves clients in the State of Massachusetts.

Estimated Revenue: $1M to $10M
Funding Status: IPO
Headquarters: Boston, Massachusetts, United States
Total Funding: 65000000
Investors Number: 2
Number Of Exists: Series B
Founded Date: 2016-01-01
Technology: Geroscience
Industry: Agetech
Last Funding Type: Series B
Investor Type: Company
Employee Number: 11-50